Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Clinton Scott

Podiatrist South Bend, IN Doctor of Podiatric Medicine

NPI 1750360137 CMS profile 1238610

3903 Portage Rd, Suite C # 161, South Bend, IN 46628

Open in the dashboard

General payments

$10,148

212 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Clinton Scott of South Bend, IN is reported in the CMS Open Payments database as having received $10,148 across 212 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Podiatrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $254 10
2024 General $663 25
2023 General $4,257 57
2022 General $1,956 25
2021 General $289 16
2020 General $1,566 26
2019 General $1,163 53

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Clinton Scott
  • Podiatrist median
  • Middle half of Podiatrist
  • National median

In program year 2025, general payments to Clinton Scott were reported at $254. Among 4,572 Podiatrist profiles paid that year, the median was $260 and the middle half received between $94 and $777.

Show as a table
Year Clinton Scott Podiatrist median Middle half National median
2019 $1,163 $196 $72–$601 $163
2020 $1,566 $118 $38–$335 $114
2021 $289 $169 $57–$573 $132
2022 $1,956 $220 $74–$782 $149
2023 $4,257 $208 $71–$635 $160
2024 $663 $237 $87–$681 $164
2025 $254 $260 $94–$777 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $2,856 84 payments
  2. KCI USA, Inc $1,418 7 payments
  3. Integra LifeSciences Corporation $1,150 25 payments
  4. Zimmer Biomet Holdings, Inc. $1,149 7 payments
  5. Organogenesis Inc. $1,036 30 payments
  6. Kerecis Limited $602 4 payments
  7. Arthrex, Inc. $486 13 payments
  8. Medwest Associates $400 2 payments
  9. Paratek Pharmaceuticals, Inc. $289 12 payments
  10. Treace Medical Concepts, Inc. $187 5 payments
  11. Other $574 23 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,255 193 payments
  2. Travel and Lodging $4,805 18 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $88 1 payment
Products named General payments · program years 2019–2025
  1. GRAFIX $1,275 12 payments
  2. STRAVIX PL $1,168 4 payments
  3. OASIS $1,168 4 payments
  4. PRIMATRIX $1,089 21 payments
  5. VAC VERAFLO $866 3 payments
  6. PREVENA $672 3 payments
  7. Kerecis Omega3 SurgiClose $602 4 payments
  8. Integra Recon-Skin And Wound $596 18 payments
  9. Integra Recon-Skin And Wound $596 18 payments
  10. Integra Recon-Skin And Wound $596 18 payments
  11. Other $11,175 229 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

31

Median for Podiatry: 160

Drug cost

$340

Median for Podiatry: $2,368

Branded share of claims

38.7%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ciclopirox Generic 19 $306
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 12 $35

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 21 billing codes

Paid by Medicare

$104,358

Medicare's payments for the services billed

Medicare patients

71

Average age 68

Services billed

713

44 women, 27 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 66%
Arthritis 56%
Heart failure 52%
Chronic kidney disease 51%
COPD 41%
Ischemic heart disease 39%
Depression 35%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
NUZYRA
  • Paratek Pharmaceuticals, Inc. $69
$69 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

212 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record